We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$622B
AUM Growth
+$11.2B
Cap. Flow
-$16.1B
Cap. Flow %
-2.59%
Top 10 Hldgs %
26.59%
Holding
3,066
New
113
Increased
1,569
Reduced
1,081
Closed
107

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$1.6B
2
VZ icon
Verizon
VZ
+$1.3B
3
USB icon
US Bancorp
USB
+$1.26B
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.26B
5
LRCX icon
Lam Research
LRCX
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 19.64%
3 Financials 12.71%
4 Consumer Discretionary 10.95%
5 Communication Services 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDT icon
2326
IDT Corp
IDT
$1.63B
$329K ﹤0.01%
11,685
+3,347
+40% +$89.7K
PRVB
2327
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$329K ﹤0.01%
31,137
+1,578
+5% +$12.7K
ACVA icon
2328
ACV Auctions
ACVA
$1.35B
$328K ﹤0.01%
39,990
+1,305
+3% +$10.9K
AVDX
2329
DELISTED
AvidXchange
AVDX
$328K ﹤0.01%
33,010
+9,297
+39% +$80.7K
HCSG icon
2330
Healthcare Services Group
HCSG
$1.43B
$328K ﹤0.01%
27,346
-10,580
-28% -$140K
MIRM icon
2331
Mirum Pharmaceuticals
MIRM
$6.02B
$328K ﹤0.01%
16,831
+4,800
+40% +$94.9K
SEI
2332
Solaris Energy Infrastructure
SEI
$3.94B
$328K ﹤0.01%
32,986
+646
+2% +$7.07K
BIG
2333
DELISTED
Big Lots, Inc.
BIG
$328K ﹤0.01%
22,339
-10,852
-33% -$187K
HOV icon
2334
Hovnanian Enterprises
HOV
$793M
$324K ﹤0.01%
7,703
-2,361
-23% -$100K
CHRS icon
2335
Coherus Oncology
CHRS
$181M
$323K ﹤0.01%
40,721
-15,055
-27% -$116K
MHH icon
2336
Mastech Digital
MHH
$92.7M
$322K ﹤0.01%
29,284
UBA
2337
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$322K ﹤0.01%
16,976
-3,973
-19% -$72.6K
MCFT icon
2338
MasterCraft Boat Holdings
MCFT
$600M
$321K ﹤0.01%
12,404
+236
+2% +$5.57K
LGTY
2339
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$321K ﹤0.01%
21,889
-3,553
-14% -$54.5K
CDMO
2340
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$319K ﹤0.01%
23,183
+1,009
+5% +$15.5K
NVTA
2341
DELISTED
Invitae Corporation
NVTA
$319K ﹤0.01%
171,498
+28,257
+20% +$69K
CVGW
2342
DELISTED
Calavo Growers
CVGW
$318K ﹤0.01%
10,817
+2,380
+28% +$79.7K
ZIMV
2343
DELISTED
ZimVie
ZIMV
$318K ﹤0.01%
34,101
+15,707
+85% +$137K
RDFN
2344
DELISTED
Redfin
RDFN
$317K ﹤0.01%
74,756
+7
+0% +$33
GHL
2345
DELISTED
Greenhill & Co., Inc.
GHL
$317K ﹤0.01%
30,928
-7,000
-18% -$60.5K
AVID
2346
DELISTED
Avid Technology Inc
AVID
$317K ﹤0.01%
11,930
-572
-5% -$15.1K
NSTG
2347
DELISTED
NanoString Technologies, Inc.
NSTG
$316K ﹤0.01%
39,702
+14,607
+58% +$127K
CNXN icon
2348
PC Connection
CNXN
$2.03B
$315K ﹤0.01%
6,724
+180
+3% +$9.04K
GIC icon
2349
Global Industrial
GIC
$1.49B
$315K ﹤0.01%
13,394
+1,867
+16% +$48.4K
FRPH icon
2350
FRP Holdings
FRPH
$425M
$314K ﹤0.01%
11,672
+174
+2% +$4.96K

Similar funds

T. Rowe Price Associates's Q4 2022 Portfolio in Review

As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
  • T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
  • T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
  • T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
  • T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
  • T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
  • T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.